TALEN

TALEN1-dusp6

ID
ZDB-TALEN-180725-1
Name
TALEN1-dusp6
Previous Names
None
Target
Target Sequence 1
5' - TCGATAAGTTCAAACCC - 3'
Target Sequence 2
5' - TCTTGCTTATGGCCAT - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Constructs
No data available
Genomic Features
Genomic Feature Affected Genomic Regions
pt30a dusp6
pt30b dusp6
pt30c dusp6
pt30d dusp6
Expression
Gene expression in Wild Types + TALEN1-dusp6
No data available
Phenotype
Phenotype resulting from TALEN1-dusp6
No data available
Phenotype of all Fish created by or utilizing TALEN1-dusp6
Phenotype Fish Conditions Figures
heart structure, ameliorated dusp6pt30a/pt30a resection: cardiac ventricle Fig. 4 with imageFig. S11 with image from Missinato et al., 2018
cardiac muscle cell increased amount, abnormal dusp6pt30a/pt30a resection: cardiac ventricle Fig. 3 with image from Missinato et al., 2018
heart fn1b expression amount, ameliorated dusp6pt30a/pt30a resection: cardiac ventricle Fig. 4 with image from Missinato et al., 2018
compact layer of ventricle increased thickness, abnormal dusp6pt30a/pt30a standard conditions Fig. 2 with image from Missinato et al., 2018
cardiac ventricle cardiac muscle cell proliferation increased process quality, abnormal dusp6pt30a/pt30a resection: cardiac ventricle Fig. 3. with image from Zuppo et al., 2023
heart contraction rhythm quality, ameliorated dusp6pt30a/pt30a resection: cardiac ventricle Fig. 4 with image from Missinato et al., 2018
whole organism dusp6 expression absent, abnormal dusp6pt30a/pt30a standard conditions Fig. 2 with image from Missinato et al., 2018
heart structure, ameliorated dusp6pt30a/pt30a chemical treatment by injection: PDGF receptor tyrosine kinase inhibitor III, resection: cardiac ventricle Fig. 6 with image from Missinato et al., 2018
cardiac muscle cell proliferation increased process quality, abnormal dusp6pt30a/pt30a resection: cardiac ventricle Fig. 3 with imageFig. 7 with image from Missinato et al., 2018
cardiac muscle tissue regeneration increased rate, abnormal dusp6pt30a/pt30a resection: cardiac ventricle Fig. 4 with image from Missinato et al., 2018
heart structure, ameliorated dusp6pt30a/pt30a chemical treatment by injection: tyrphostin AG 1478, resection: cardiac ventricle Fig. S11 with image from Missinato et al., 2018
heart errfi1b expression increased amount, abnormal dusp6pt30a/pt30a resection: cardiac ventricle Fig. 7 with image from Missinato et al., 2018
heart col12a1a expression amount, ameliorated dusp6pt30a/pt30a resection: cardiac ventricle Fig. 4 with image from Missinato et al., 2018
heart increased size, abnormal dusp6pt30a/pt30a standard conditions Fig. 2 with image from Missinato et al., 2018
heart cybb expression amount, ameliorated dusp6pt30a/pt30a resection: cardiac ventricle Fig. 4 with image from Missinato et al., 2018
heart postna expression amount, ameliorated dusp6pt30a/pt30a resection: cardiac ventricle Fig. 4 with image from Missinato et al., 2018
cardiac muscle cell proliferation increased process quality, abnormal dusp6pt30d/pt30d resection: cardiac ventricle Fig. S4 with image from Missinato et al., 2018
compact layer of ventricle increased thickness, abnormal dusp6pt30a/pt30a; y1Tg standard conditions Fig. 2 with image from Missinato et al., 2018
cardiac muscle tissue regeneration increased rate, abnormal dusp6pt30a/pt30a; y1Tg resection: cardiac ventricle Fig. 3 with image from Missinato et al., 2018
regenerating tissue angiogenesis increased process quality, abnormal dusp6pt30a/pt30a; y1Tg resection: cardiac ventricle Fig. 3 with image from Missinato et al., 2018
compact layer of ventricle blood vessel increased amount, abnormal dusp6pt30a/pt30a; y1Tg standard conditions Fig. 2 with image from Missinato et al., 2018
compact layer of ventricle blood vessel ab2-mapk labeling increased amount, abnormal dusp6pt30a/pt30a; y1Tg standard conditions Fig. 2 with image from Missinato et al., 2018
cardiac ventricle cardiac muscle cell proliferation decreased process quality, abnormal foxm1sa10708/sa10708; dusp6pt30a/pt30a resection: cardiac ventricle Fig. 3. with image from Zuppo et al., 2023
Citations